Hematologic Diseases  >>  Jakafi (ruxolitinib)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jakafi (ruxolitinib) / Incyte
NCT02469974: Ruxolitinib in Combination With Autotransplant

Withdrawn
N/A
0
US
RUXOLITINIB / INC 424, RUX, Jakafi®, Filgrastim, Neupogen®, Busulfan, Busulfex®
Marina Kremyanskaya, Incyte Corporation
Myelofibrosis, MF
08/16
08/16
NCT01730755: Ruxolitinib for Chuvash Polycythemia

No Longer Available
N/A
US
Ruxolitinib, Jakafi
Washington University School of Medicine, Incyte Corporation
Erythrocytosis, Familial, 2
 
 

Download Options